Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Express News | Bank of America Securities has lowered the Target Price for Thermo Fisher Scientific from $675.00 to $660.00.
Thermo Fisher Is Maintained at Buy by B of A Securities
Thermo Fisher Scientific Analyst Ratings
BofA Securities Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $660
Express News | Thermo Fisher Scientific Inc : Jefferies Cuts Target Price to $650 From $655
Thermo Fisher Scientific To Go Ex-Dividend On December 13th, 2024 With 0.39 USD Dividend Per Share
December 11th (Eastern Time) - $Thermo Fisher Scientific(TMO.US)$ is trading ex-dividend on December 13th, 2024.Shareholders of record on December 13th, 2024 will receive 0.39 USD dividend per share
TMO Institutional & Insider Stock Sell-Offs Upset Market: How to Play
Should You Continue to Hold TMO Stock in Your Portfolio?
India Microfluidics Market Report 2024, With Profiles of AQC Chem. Lab, Bio-Rad Laboratories India, Abbott India, PerkinElmer India and Thermo Fisher Scientific India
Synthetic Biology Focused Insights Report 2024-2029 With Competitive Analysis of 38 Vendors - Agilent, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific Lead - ResearchAndMarkets.com
RBC Trims Price Target on Thermo Fisher Scientific to $711 From $718, Keeps Outperform Rating
17 Stocks With Rebounding Operating Margins – Goldman
How Is Thermo Fisher Scientific's Stock Performance Compared to Other Medical Devices Stocks?
TMO Stock to Gain From the New Additions to CTS Portfolio of Products
Thermo Fisher Scientific(TMO.US) Officer Sells US$10.62 Million in Common Stock
$Thermo Fisher Scientific(TMO.US)$ Officer CASPER MARC N sold 20,000 shares of common stock on Dec 2, 3, 2024 at an average price of $531.23 for a total value of $10.62 million.Source: Announcement
Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing
Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production
Thermo Fisher Scientific Completes $1B Share Repurchase